Epithelial–mesenchymal transition confers resistance to selective FGFR inhibitors in SNU-16 gastric cancer cells
Paulina Grygielewicz(Celon Pharma (Poland)), Daria Zdżalik-Bielecka(International Institute of Molecular and Cell Biology)
Cited by 70
Related Papers
Activating mutations in ALK kinase domain confer resistance to structurally unrelated ALK inhibitors in NPM-ALK-positive anaplastic large-cell lymphoma
|Journal of Cancer Research and Clinical Oncology|2014|36
GAS6-AXL signaling triggers actin remodeling and macropinocytosis that drive cancer cell invasion
|bioRxiv (Cold Spring Harbor Laboratory)|2020|1